v3.25.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Federal grants $ 1,371,438 $ 181,797 $ 2,691,210 $ 487,519
Operating expenses:        
Research and development 1,923,430 947,229 3,808,957 1,726,133
General and administrative 1,198,523 1,190,010 2,600,279 2,559,791
Total operating expenses 3,121,953 2,137,239 6,409,236 4,285,924
Loss from operations (1,750,515) (1,955,442) (3,718,026) (3,798,405)
Other income (expense):        
Change in fair value of liability classified warrants (853) 7,818 9,063 16,773
Interest expense, net (3,160) (27,563) (7,017) (1,275,628)
Other income and expense, net 21,011 7,394 36,890 (27,096)
Total other income (expense), net 16,998 (12,351) 38,936 (1,285,951)
Net loss (1,733,517) (1,967,793) (3,679,090) (5,084,356)
Net loss attributable to noncontrolling interests (166) (166) (74)
Deemed dividend related to warrants down round provision 290
Net loss attributable to common stockholders $ (1,733,351) $ (1,967,793) $ (3,678,924) $ (5,084,572)
Net loss per basic and diluted share:        
Net income (loss) per share attributable to common stockholders, basic $ (0.79) $ (3.35) $ (2.04) $ (9.98)
Net income (loss) per share attributable to common stockholders, diluted $ (0.79) $ (3.35) $ (2.04) $ (9.98)
Weighted average common shares outstanding, basic 2,202,299 587,822 1,803,393 509,347
Weighted average common shares outstanding, diluted 2,202,299 587,822 1,803,393 509,347

Source